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Editorial on the Research Topic
Neuropeptides and Behavior: From Motivation to Psychopathology
The discovery of the involvement of neuropeptides with behaviors other than regulatory motivated 
ones took place in the mid-1960s with David de Wied’s first report on the influence of stress hormones, 
such as ACTH and arginine vasopressin (AVP) infused intra-cerebroventricularly, on memory (1). 
This major scientific breakthrough opened a new frontier of studies in Endocrinology and its related 
fields, Neuroendocrinology and Psychoneuroendocrinology.
Neuropeptides were thought to be involved in homeostatic regulation and secreted only from 
hypothalamic neurons; they are now recognized neurotransmitters, produced in, and secreted from 
distinct brain areas, associated with a myriad of, not only motivated but also psychopathological 
behaviors (2). Motivated behaviors are determinant for individual and species survival, but their 
expression in a large spectrum and deviations from average may give rise to a number of psychiatric 
conditions.
This research topic brings together 3 original studies and 10 review papers on the regulatory 
role of neuropeptides on sleep, feeding-, maternal-, and social behaviors. In addition, the implica-
tion of neuropeptides on both ends of this spectrum—lack of or excessive motivation—will also be 
discussed, as more and more, changes in neuropeptide production such as neuropeptide Y (NPY), 
oxytocin (OT), corticotropin-releasing hormone/factor (CRH/CRF), orexin, melanin-concentrating 
hormone (MCH), prolactin, and opioids have been associated with depression, anxiety, drug addic-
tion, eating, and social disorders.
Pomrenze and colleagues used a transgenic rat that expresses CRH immunoreactive neurons, and 
they were able to show that this rat is a useful tool to study CRH projections, mainly from the central 
nucleus of the amygdala and the bed nucleus of the stria terminalis. CRH is the primary mediator 
of the hypothalamic–pituitary–adrenal axis stress response, subjected to plasticity and adaptations 
in cases of chronic stress exposure. Herman and Tasker presented a review of the mechanisms 
involved in the adaptations of the stress response at the level of the paraventricular nucleus of the 
hypothalamus, including the enhancement of CRH and AVP production, reduced glucocorticoid 
negative feedback activity, and increased excitatory neurotransmission at the CRH neurons. These 
converging alterations lead to increased CRH activity, characteristic of a number of stress-related 
psychiatric disorders.
In recent years, dysregulation of extra-hypothalamic CRF systems has gained attention in the 
context of alcohol use disorders. Quadros and colleagues presented a comprehensive review on 
the role of CRF and urocortin systems (and their related elements), in alcohol-induced escalated 
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aggression, and in the transition from alcohol use to depend-
ence, due to the direct modulation of CRF on the brain reward 
system.
In mice, chronic administration of low doses of ethanol 
produce a stimulatory action, inducing a phenomenon known 
as behavioral sensitization, which reflects neurobiological 
modifications in the reward system. Kawakami and co-workers 
showed that expression of behavioral sensitization can be blocked 
by naltrexone, an antagonist of the μ and, to a lesser extent, of 
the κ opioid receptors, in a sex-dependent manner, with greater 
efficiency in males than in females.
Keil and colleagues explored the involvement of the cyclic 
AMP/protein kinase A (cAMP/PKA) signaling pathway in 
anxiety and depressive disorders, by means of amygdala hyper-
activation induced by stressful conditions. PKA is involved in 
the regulation of a myriad of intracellular signals triggered by 
distinct neurotransmitter systems related to alertness, mood, and 
acute and social anxiety. This mechanism of plasticity could be 
important for the proposition of new therapeutic strategies for 
conditions that afflict the human population.
Stress recruits numerous neuromodulators and neuropeptides 
that provide optimal coping conditions and adaptive responses. 
One such response is increased sleep time, especially of REM 
sleep, after a stressful event. Machado and Suchecki reviewed 
the neuropeptidergic and hormonal mechanisms involved in 
sleep induced by stressful situations. In Wellman and coworker’s 
original article, escapable shock, a model of controllable stress, 
increased REM sleep, whereas inescapable shock reduces this 
sleep stage. CRF blocked this positive response to controllable 
stress, whereas astressin, a CRF receptor 1 antagonist, restored 
sleep to control levels.
Melanin-concentrating hormone was the focus of Torterolo 
and colleagues’ review with special emphasis on recent elec-
trophysiological recordings and optogenetic stimulation. 
The authors argued that the greatest firing rate of MCHergic 
neurons occurred during REM sleep and remote stimulation of 
those neurons induced sleep. The authors also focused on MCH 
projections to the dorsal raphe nucleus and the potential role of 
MCH in the pathophysiology of depression.
Neuropeptide Y and its receptors have a key role in central con-
trol of energy homeostasis, sleep, circadian rhythm, memory, and 
neuronal plasticity. Thorsell and Mathé presented an overview of 
NPY action on anxiety and stress response, and potentially post-
traumatic stress disorder and depression. The authors discussed 
genetic and epigenetic findings of importance for NPY function 
and regulation and proposed that the modulation of NPY-ergic 
activity within the brain constitute potential targets for interven-
tion in affective and alcohol use disorders.
Circulating hormones are also key players in motivation and 
behavioral adaptations. Among the most versatile of them is 
prolactin (PRL). Torner highlighted the role of PRL in neurogen-
esis and stress responses in the male brain. The author showed 
strong argument supporting the hypothesis that alterations in 
the PRL system due to stress or exposure to substances or other 
conditions that reduce neurogenesis may contribute to maladap-
tive responses and pathological behavioral outcomes. The author 
discussed the effects of PRL on neurogenesis and neuroprotection 
and their potential contribution to the onset of psychopathologi-
cal states such as depression.
Oxytocin is a neuropeptide synthesized primarily by 
neurons of the paraventricular and supraoptic nuclei of the 
hypothalamus. These neurons are part of the magnocellular 
neurosecretory system, releasing OT into the posterior pitui-
tary to promote labor and lactation. However, OT neurons also 
project to other brain sites and regulate homeostatic processes, 
social recognition, and fear conditioning. OT also decreases 
neuroendocrine stress signaling pathway, anxiety, and 
depression-like behaviors. Acevedo-Rodriguez and colleagues 
presented data showing that steroid hormones differentially 
modulated stress responses and altered OT receptor expres-
sion. The authors emphasized the role of estrogen receptor β 
activation and suggested a role for OT in this estrogen receptor 
β-mediated anxiolytic effect.
The function of neuropeptides and hormones is modulated 
by neuronal plasticity, synaptic strength, and morphological 
changes. Cabral and colleagues focused on the importance of 
mechanisms associated with the permeability of the blood 
brain barrier (BBB) and the interplay among delicate ana-
tomical interfaces that have the potential to alter physiology 
and behavior. Authors used ghrelin, a hormone produced by 
the stomach with important role in energy homeostasis and 
motivated behaviors. Ghrelin receptors are widespread in the 
brain, but the accessibility of the hormone is strikingly low. 
This neuroendocrine issue is discussed in light of the dynamic 
control of the BBB.
Another aspect discussed in this issue is the crucial role of 
synaptic strength and interaction in physiology and behavior. 
Woelfle and colleagues discussed the effect of TCAP (short amino 
acid sequence found in the distal extracellular tip of teneurin) 
and the LPHN ligand–receptor system in anxiety, stress, and 
mood disorders. The teneurin TCAP protein binds and activates 
the LPHNs, a family of adhesion-associated GPCRs, to regulate 
numerous neurological and physiological activities. The long-
lasting effect of exogenous TCAP and the current molecular 
model of ligand–receptor interaction suggest a role in neuronal 
plasticity and behavioral modulation.
Understanding the interplay between neuropeptides and 
hormones in the control of motivation and behavioral responses 
is highly relevant for human’s physical and mental health. Clearly, 
research in this field is advancing at a rapid pace. The articles in 
this eBook highlight novel findings and unanswered questions for 
future investigation.
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